OBJECTIVES: This study measured the serum concentrations of resistin and adiponectin in Chinese subjects with impaired glucose tolerance (IGT) and investigated their association with insulin resistance, metabolic parameters and circulating inflammatory markers. METHODS: A total of 124 subjects participated in the study (44 with IGT and 80 with normal glucose tolerance [NGT]). Fasting serum concentrations of lipids, glucose, insulin and adipocytokines (resistin, adiponectin, leptin, tumour necrosis factor-a [TNF-a], interleukin-6 and C-reactive protein) were measured. RESULTS: Serum resistin concentrations were similar in the IGT and NGT groups but were significantly higher in overweight/ obese IGT subjects than in those of normal weight. Serum adiponectin concentrations were significantly lower in the IGT group than in the NGT group. In the IGT group, resistin was positively correlated with age, body mass index and TNF-a, and adiponectin was correlated positively with high-density lipoprotein cholesterol and negatively with TNF-a and waist/hip ratio. CONCLUSIONS: Circulating resistin is unlikely to be a major mediator of glucose tolerance in humans but it may have an inflammatory role in IGT. The data support the theory that circulating adiponectin has an anti-inflammatory and anti-insulin resistance function.
Introduction
Adipose tissue secretes a number of adipocytokines, including resistin, adiponectin, leptin, tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and has been presumed to play an active role in metabolic regulation, insulin resistance and insulin resistancerelated diseases. 1,2 Studies have suggested potential associations between adipocytokines and glucose tolerance states, 3 -6 but the Resistin and adiponectin in impaired glucose tolerance precise mechanism determining these states in humans remains unclear.
Resistin was discovered in 2001 by Steppan et al. 7 and has been postulated to cause insulin resistance and to play a role in the relationship between obesity and insulin resistance in mice. Circulating resistin has a physiological function in the maintenance of glucose homeostasis and glucose tolerance. 3 -9 Mice that lack resistin exhibit lower blood glucose levels after fasting, 2 and circulating resistin concentrations are inversely associated with glucose tolerance in mice, indicating a role in impaired glucose tolerance (IGT). 4, 5, 7 The role of resistin in humans remains controversial, however, with some studies indicating an association with inflammation. 10, 11 In spite of considerable effort, little is known about the physiological function of human resistin. 12 There are few data concerning circulating resistin concentrations in subjects with IGT, and the limited clinical studies that are available have not been able to show any clear relationship between resistin and glucose homeostasis or insulin resistance. 3, 8, 9 Adiponectin is an adipocyte-specific secreted protein that sensitizes the liver and muscles to the action of insulin, 13 acting as a regulator of insulin sensitivity in both humans and rodents. 14, 15 Circulating adiponectin concentrations have been shown to be decreased in patients with insulin resistance and type 2 diabetes, 6,16,17 as well as in subjects with prediabetic conditions such as IGT, 6,18 -20 but the findings of clinical studies have been inconsistent. 9, 21, 22 Circulating adiponectin has also been shown to have anti-inflammatory and antiarteriosclerotic functions. 14, 15, 19 The aim of the present study was to determine the serum concentrations of resistin and adiponectin in Chinese subjects with IGT and to investigate their associations with insulin resistance, metabolic parameters and circulating inflammatory markers.
Subjects and methods

STUDY POPULATION
This study at the Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China, recruited volunteers from the local population of Nanchong between April and May 2006. All subjects were in good general health with normal kidney and liver function and were chosen according to the following criteria: (i) no regular alcohol or drug consumption; (ii) no history of any metabolic disorder, renal disease, cerebrovascular or cardiovascular disease; (iii) no current treatment with any drug that alters glucose tolerance. Individuals with a history of acute illness within the previous 2 weeks were excluded to avoid any effects on the serum concentrations of inflammatory proteins. Blood pressure, body weight, height, and waist and hip circumference were measured according to the criteria of the World Health Organization. 23, 24 Body mass index (BMI) was calculated as weight (kg) / height (m) 2 .
Written informed consent was obtained from all of the volunteers and the study was approved by the Ethics Committee of the Affiliated Hospital of North Sichuan Medical College.
OGTT
All participants underwent an oral glucose tolerance test (OGTT) with 75 g glucose. Blood samples were obtained 2 h after the oral glucose load for determination of serum glucose concentration. Blood was allowed to clot for 30 min, centrifuged at 800 g for 10 min at 4°C, and serum was stored at -80°C until analysis with a Hitachi 902 autoanalyser (Roche Diagnostic Systems, Resistin and adiponectin in impaired glucose tolerance Branchburg, NJ, USA). Subjects were divided into two groups on the basis of serum glucose concentration: IGT group, serum glucose ≥ 7.8 mmol/l; normal glucose tolerance (NGT) group, serum glucose < 7.8 mmol/l. 25 
LABORATORY PARAMETERS
Peripheral venous blood was obtained after a 12 h fast. Serum was prepared and stored as described for the OGTT. Fasting glucose, triglyceride (TG), total cholesterol (TC), highdensity lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), were quantified using the Hitachi 902 autoanalyser. Serum concentrations of IL-6, TNF-α and resistin were determined using enzyme-linked immunosorbent assay kits (Invitrogen, Camarillo, CA, USA). Insulin, Cpeptide, leptin and adiponectin were quantified using commercially available radioimmunoassay kits (Linco Research, St Louis, MO, USA). C-reactive protein (CRP) concentration was determined using a human CRP antibody bead kit (Invitrogen). All kits were used according to the manufacturer's instructions and the intraand interassay coefficients of variation were < 10%. Insulin resistance was calculated using the homeostasis model assessment (HOMA-IR) 26 as follows: serum glucose (mmol/l) × fasting insulin (µU/ml) / 22.5.
STATISTICAL ANALYSES
Data were presented as mean ± SD. Resistin, adiponectin, leptin, TNF-α and IL-6 data were normalized by logarithmic transformation. Between-group differences were analysed using Student's t-test for continuous variables and the χ 2 -test for categorical variables. The relationships of resistin and adiponectin concentrations with the various measured indices were assessed by Pearson's correlation coefficient. Multiple linear regression analysis, using resistin and adiponectin as dependent variables, was performed on those variables found to have statistically significant correlations to determine which of them were independent factors for influencing resistin and adiponectin concentrations. Statistical analyses were performed using SPSS ® version 11.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . A P-value < 0.05 (two-tailed) was considered to be statistically significant.
Results
A total of 124 volunteers (NGT group n = 80; IGT group n = 44) were recruited to the study Their anthropometric and laboratory characteristics are shown in Table 1 . Age, BMI, systolic blood pressure, waist/hip ratio, HOMA-IR, TC, LDL-C, fasting glucose, OGTT glucose, insulin, C-peptide, CRP and leptin concentrations were significantly higher in the IGT group than in the NGT group (P = 0.036 -P < 0.001). Serum adiponectin concentration was significantly lower in the IGT group than the NGT group (P = 0.014). There were no significant between-group differences in diastolic blood pressure or the serum concentrations of TG, HDL-C, IL-6, TNF-α or resistin.
Laboratory data from the IGT group stratified according to BMI (normal weight [BMI < 25 kg/m 2 ], n = 23; overweight/obese [BMI ≥ 25 kg/m 2 ], n = 21) are shown in Table  2 . Serum insulin, IL-6, TNF-α and resistin concentrations and HOMA-IR were significantly higher in overweight/obese subjects compared with those of normal weight (P = 0.03 -P = 0.004). There were no significant between-group differences in serum adiponectin or leptin concentrations.
In the IGT group, resistin concentration was positively correlated with age (r = 0.537, P < 0.001), BMI (r = 0.331, P = 0.028) and TNF-α (r = 0.324, P = 0.032) ( Fig. 1) . Adiponectin concentration was positively Resistin and adiponectin in impaired glucose tolerance correlated with HDL-C (r = 0.667, P < 0.001) and inversely correlated with waist/hip ratio (r = -0.317, P = 0.036) and TNF-α (r = -0.515, P = 0.001) (Fig. 2 ). There were no relationships between serum resistin or adiponectin and fasting glucose, insulin or OGTT glucose concentrations or HOMA-IR. There was a significant positive correlation between HOMA-IR and CRP level (r = 0.437, P = 0.003).
In the NGT group, resistin concentration was positively correlated with age (r = 0.226, P < 0.001), systolic blood pressure (r = 0.302, P = 0.007) and TNF-α (r = 0.405, P = 0.043), and inversely correlated with HOMA-IR (r = -0.223, P = 0.046). There were inverse correlations between adiponectin concentration and waist/hip ratio (r = -0.264, P = 0.018), fasting insulin concentration (r = -0.223, P = 0.047) and TG concentration (r = -0.222, P = 0.048).
Multiple linear regression analysis using resistin and adiponectin as dependent variables revealed that the independent factors for resistin concentration were age (P < 0.001) and BMI (P = 0.007) in the IGT group, and TNF-α (P < 0.001) and systolic 1.80 2.00 Log resistin concentration (ng/ml) Resistin and adiponectin in impaired glucose tolerance blood pressure (P = 0.001) in the NGT group. The independent factors for adiponectin concentration were HDL-C (P < 0.001) and the female gender (P = 0.016) in the IGT group, and fasting insulin (P = 0.032) and waist/hip ratio (P = 0.043) in the NGT group.
Discussion
Adipose tissue has been recognized as an endocrine organ that plays a pivotal role in insulin resistance and glucose homeostasis by secreting signalling molecules known as adipocytokines. 1,2 The exact role of adipocytokines, such as adiponectin and resistin, in glucose metabolism and their physiological function in humans remains under investigation. 3 -6 Serum adiponectin concentrations were reduced in the IGT group in the present study and resistin levels were increased in overweight/obese IGT subjects. The serum concentration of the inflammatory marker TNF-α correlated positively with resistin and negatively with adiponectin in the IGT group, suggesting that circulating resistin may have an inflammatory role in IGT. HOMA-IR and fasting glucose, insulin and C-peptide concentrations were significantly higher in the IGT group than in the NGT group, but there were no significant correlations between circulating resistin and adiponectin and these parameters in subjects with IGT.
Resistin has been reported to impair glucose tolerance in normal mice by inhibiting insulin-stimulated glucose uptake, with the resulting decreased insulin 27 Resistin is associated with obesity and type 2 diabetes in animal models, but its role in humans remains uncertain. 3, 8, 12 Serum resistin concentrations in the IGT group were not significantly different from those in the NGT group in the present study, and there was no correlation between circulating resistin concentration and either the OGTT glucose concentration or HOMA-IR in the IGT group. This lack of correlation between glucose intolerance and resistin concentrations might be explained by the fact that macrophages rather than adipocytes are the major source of resistin in humans. 28 The molecular structure of resistin is similar to the structures of proteins that are involved in inflammation. 29 Studies in humans have demonstrated increased circulating resistin concentrations in acute inflammation that correlated positively with inflammatory markers. 10, 11 In addition, treatment with recombinant resistin has been shown to upregulate the expression of cytokines and adhesion molecules in human endothelial cells. 30 The association between serum resistin and TNF-α concentrations in the current study supports the hypothesis that circulating resistin may play a more inflammatory than metabolic role in humans. Inflammatory markers, such as CRP and IL-6, have been shown to be predictors of type 2 diabetes and are associated with insulin resistance and insulin resistance-related diseases. 31, 32 It is, therefore, possible that inflammation may be the link between circulating resistin concentrations and insulin resistance and type 2 diabetes.
Studies have indicated increased serum resistin concentrations in diet-induced obese mice and rats. 7, 33, 34 In agreement with others, 3,35,36 the present study found increased resistin concentrations in overweight/obese IGT subjects and a significant positive correlation with BMI, indicating an association between the circulating resistin concentration and obesity in humans. The adipocytokines IL-6 and TNF-α, which are markers of the inflammatory process, were also increased in the overweight/obese subjects in the IGT group in the present study, suggesting a connection between obesity and inflammation in IGT.
Circulating resistin concentrations were positively correlated with age in the IGT group in the present study. To the best of our knowledge, there are few reports concerning the relationship between circulating resistin levels and age in humans. Studies in mice have indicated a tendency for circulating resistin concentrations to be inversely correlated with age, 37,38 although the underlying mechanism remains unknown. Dehydroepiandrosterone is decreased in aged mice and this may upregulate resistin gene expression in white adipose tissue. 39 One study in humans reported, however, that circulating resistin levels were positively correlated with age in humans. 35 The difference in the relationship between serum resistin concentrations and age in humans and mice might be due to the different sources of resistin in humans and mice (i.e. macrophages versus adipocytes). 7, 28 It is well known that circulating adiponectin decreases in patients with insulin resistance-related diseases, such as obesity and type 2 diabetes, 6,19,20 but it is not clear whether adiponectin is decreased in IGT. Adiponectin has been shown to enhance fat oxidation and glucose transportation in muscle in vitro. 12 Studies have demonstrated an inverse correlation between serum adiponectin and glucose tolerance, with reduced circulating adiponectin in IGT subjects. 6,18 -20 On the other hand, others have found that circulating R Luo, X Li, R Jiang et al. Resistin and adiponectin in impaired glucose tolerance adiponectin concentrations were normal in IGT. 9, 21, 22 Adiponectin concentrations were significantly lower in the IGT group than the NGT group in the current study, suggesting a possible association between circulating adiponectin concentration and glucose tolerance. There was no association between adiponectin concentration and HOMA-IR in the IGT group in the present study, but serum concentrations of adiponectin were inversely correlated with TNF-α in subjects with IGT. Reports have indicated the existence of a link between these two adipocyte hormones. 40, 41 TNF-α has been shown to be involved in the induction of insulin resistance in humans, 42, 43 and treatment with recombinant adiponectin induced a reduction in TNF-α expression in mice. 40 The results of the present study support the theory that circulating adiponectin has anti-inflammatory and anti-insulin resistance functions in humans. 14 -19 This study had a number of limitations, including a potential bias associated with the participation of healthy volunteers. Surprisingly, in spite of the significant age difference between the IGT and NGT groups, there were no correlations between serum resistin or adiponectin concentrations and age. In addition, the outcomes of subjects in the IGT group may have been influenced by the much smaller sample size compared with the NGT group. Larger studies are, therefore, required to investigate further potential associations between circulating resistin and adiponectin concentrations and insulin resistance, metabolic parameters and circulating inflammatory markers.
In conclusion, this study in a Chinese population found decreased serum adiponectin concentrations in IGT compared with NGT. Resistin concentrations were significantly increased in overweight/obese subjects with IGT. Serum resistin is unlikely to be a major mediator of glucose tolerance in humans, but it may have an inflammatory role in IGT. The data support the theory that circulating adiponectin has anti-inflammatory and anti-insulin resistance functions.
